Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Medarex presents MDX-210 phase I/II interim results

May 24, 1996

ImClone, E. Merck continue cancer vaccine collaboration

May 24, 1996

Vical, Corixa to collaborate on immunotherapeutic drugs for cancer

May 24, 1996

Patent protection obtained for IDEC-C2B8

May 24, 1996

Genentech completes investment in IDEC ahead of schedule

May 17, 1996

U.S. NDA filed for bropirimine

May 17, 1996

Promising clinical data for GVAX reported at scientific meeting

May 17, 1996

Human Genome Sciences claims chemokine beta-9 polypeptides and their antagonists

May 17, 1996

Melacine NDA filing in sight

May 10, 1996

Jenner Technologies in-licenses MTP-PE from Ciba

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...